Hot Pursuit     17-Jun-24
Zydus Life’s Gujarat facility gets OAI status from USFDA
Zydus lifesciences said that US Food and Drug Administration (USFDA) classified the inspection conducted at its injectables manufacturing facility located at Ahmedabad in March 2024 as OAI (Official Action Indicated).
Further, the regulatory agency has granted a teleconference Regulatory Meeting to discuss all the implemented and proposed actions. The company said that it will work closely with the agency to resolve this regulatory status of this facility expeditiously. The inspection was conducted from 18th March to 27th March 2024 located at Pharmez Special Economic Zone, Matoda, Gujarat, India.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The pharma major reported consolidated net profit of Rs 1,182.3 crore in Q4 FY24 steeply higher than Rs 296.6 crore recorded in Q4 FY23. Revenue from operations jumped 10.44% to Rs 5,533.8 crore during the quarter as compared with Rs 5,010.6 crore posted in corresponding quarter last year.

The scrip rose 1.70% to end at Rs 1108.80 on Friday, 14, June 2024. The stock market is closed today on account of Bakri-Id.

Previous News
  Barometers end with minor gains; broader mkt outperforms
 ( Market Commentary - Quick Review 18-May-24   12:44 )
  Zydus Life gets US FDA nod for seizure treatment drug Lacosamide
 ( Hot Pursuit - 16-Dec-23   15:37 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Zydus Life’s Gujarat facility gets OAI status from USFDA
 ( Hot Pursuit - 17-Jun-24   08:58 )
  Zydus Life gains on USFDA nod for phase 2 clinical trial of ZYIL1
 ( Hot Pursuit - 18-Dec-23   09:22 )
  Zydus Life gets EIR from USFDA for Ahmedabad facility
 ( Hot Pursuit - 11-May-23   12:04 )
  Zydus Life gets USFDA nod for antidepressant drug
 ( Hot Pursuit - 18-Aug-23   12:25 )
  Zydus Life gets USFDA nod for Sugammadex injection
 ( Hot Pursuit - 06-Oct-23   14:57 )
  Zydus Lifesciences Ltd spurts 1.42%, up for third straight session
 ( Hot Pursuit - 07-Aug-23   13:05 )
  Nifty hovers above 17,100; pharma shares gain
 ( Market Commentary - Mid-Session 22-Mar-23   14:33 )
  Zydus Life receives EIR from USFDA for Ahmedabad facility
 ( Hot Pursuit - 03-Jul-23   11:22 )
Other Stories
  Wipro Q1 PAT rises 6% QoQ to Rs 3,003 cr
  19-Jul-24   17:22
  BPCL tanks after Q1 PAT slides 71% YoY to Rs 3,015 cr in FY25
  19-Jul-24   15:45
  Fedbank Financial Services Q1 PAT rises 4% YoY to Rs 70 cr
  19-Jul-24   15:33
  UltraTech Cement Q1 PAT rises YoY to Rs 1,697 crore
  19-Jul-24   15:32
  Jubilant Pharmova hits 52-week high after Q1 PAT zooms to Rs 482 cr
  19-Jul-24   15:06
  Chennai Petroleum Corporation Ltd leads losers in 'A' group
  19-Jul-24   15:00
  Nakoda Group of Industries Ltd Partly Paidup leads losers in 'B' group
  19-Jul-24   14:45
  Volumes spurt at AIA Engineering Ltd counter
  19-Jul-24   14:30
  Metal stocks edge lower
  19-Jul-24   14:00
  Real Estate stocks edge lower
  19-Jul-24   14:00
Back Top